Abbreviation Key: BHI = brain heart infusion; Cc = cellular drug concentration; Ce = extracellular drug concentration; LPS = lipopolysaccharide; MIC = minimum inhiboatory concentration.
INTRODUCTION
Tilmicosin is a semi-synthetic macrolide antibiotic (Bryskier et al., 1993) currently approved for veterinary use in cattle and swine respiratory disease (Shryock et al., 1994; Moore, 1996; Moore et al., 1996) . It has in vitro activity against several Gram-negative bacteria associated with respiratory disease such as Actinobacillus pleuropneumoniae, Pasteurella multocida, and Pasteurella haemolytica, in addition to mycoplasma (Ose, 1987; Salmon et al., 1995) . In order to explore the application of tilmicosin for treating poultry with air sacculitis, two studies were performed. An experimental infection of broiler chickens with Mycoplasma gallisepticum was successfully controlled by tilmicosin incorporated in the diet (Shryock et al., 1994) , and an experimental infection of broiler chickens with Mycoplasma synoviae was successfully controlled by tilmicosin administered in the drinking water (Jordan and Horrocks, 1996) . Further studies on the pharmacokinetics of tilmicosin in chickens by Warren et al. (1997) have shown that tilmicosin is distributed in the chicken lungs and airsacs in a concentration (2.30 ± 0.72 mg/g lung after 48 h of oral treatment) that exceeds the minimum inhibatory concentration (MIC) for M. gallisepticum (0.0125 mg/mL, Jordan and Horrocks, 1996) and M. synoviae (0.1 mg/mL, Jordan and Horrocks, 1996) .
The interaction of antibiotics with phagocytes, and their influence on the fate of intraphagocytic bacteria may be of therapeutic importance. The ability of an antimicrobial agent to penetrate into phagocytic cells is essential for activity against intracellular organisms (Mandel, 1973; Miller et al., 1984; Hoger et al., 1985; Scorneaux et al., 1989; Meyer et al., 1993) . Although it has been demonstrated that most antimicrobial agents have limited cellular penetration (Johnson et al., 1980; Prokesch and Hand, 1982; Hand et al., 1984 Hand et al., , 1987 , only a 2 Sigma Chemical Co., St. Louis, Elanco Animal Health, Greenfield, IN 46140. 4 Eli Lilly and Co., Indianapolis, IN 46285. 5 ICN Pharmaceuticals, Inc., Costa Mesa, CA 92626. 6 Difco Laboratories, Detroit, MI 48232-7058. 7 Hoover's Hatchery, Inc., Rudd, IA 50471. 8 Fisher Scientific, Norcross, GA 30091. few are accumulated by phagocytes (Steinberg and Hand, 1984; Scorneaux et al., 1987; Tulkens, 1991; Butts, 1994) . Among these, macrolide antibiotics have been studied extensively (Kirst and Sides, 1989; Labro, 1993) using human and rat phagocytes Hand et al., 1987; Gladue et al., 1989; Hand and Hand, 1993; Mtairag et al., 1995) . Gladue et al. (1989) have shown that azithromycin, an azalide antibiotic, attained intracellular concentrations up to 200 times the external concentration in vitro. They also showed a targeted delivery of active drug to remote infection sites by the phagocyte. It was speculated that accumulation, transport, and delivery of antibiotic could provide a potential advantage to the host because of the important implications for in vivo antibacterial efficacy.
The objectives of the present study were to investigate in vitro the ability of tilmicosin to concentrate in chicken phagocytic cells, be transported, and released as bioactive tilmicosin at distant sites, and explore the effect of tilmicosin on antibacterial lysosomal enzymes.
MATERIALS AND METHODS

Chemicals and Reagents
Sodium cyanide, potassium fluoride, Histopaque 1.077, Histopaque 1.119, pentoxifylline, chloroquine, lipopolysaccharide (LPS), NaCl, formaldehyde, methylcellulose, sucrose, imidazole, EDTA, formyl-methionineleucine-phenylanaline, bafilomycin, ammonium chloride, Leibovitz medium, McCoy medium and RPMI-1640 medium were obtained from Sigma Chemical Co. 2 Tilmicosin was obtained from Elanco Animal Health. 3 Radiolabeled [ 14 C]-tilmicosin was synthesized by the Radiopharmaceutical Group at Eli Lilly and Co. 4 Labeled drug had a radiopurity of 95% and a specific activity of 2.32 mCi/mg. The bioactivity of the labeled tilmicosin was verified by comparing the MIC of this drug (MIC range 2 to 8 mg/mL ± 1 dilution) with those obtained with the corresponding unlabeled drug (MIC range 2 to 8 mg/mL ± 1 dilution) against five strains of P. multocida.
[3H]-Water (specific activity 100 mCi/mL) and [ 14 C]-carboxyinulin (specific activity 4.36 mCi/g) were purchased from ICN Pharmaceuticals, Inc. 5
Bacteria
Avian Staphylococcus aureus was kept on blood agar plates and subcultured every day. For each experiment, a 6-h culture of the organism in Trypticase soy broth 6 was made. The turbidity of this culture was adjusted to that of a 0.5 McFarland standard (approximately 10 8 cfu/mL) at 650 nm. Avian P. multocida ATCC 15742, was inoculated into 20 mL of fresh brain heart infusion (BHI 6 ) broth and incubated on an orbital shaker at 100 rpm at 41 C for 4 h.
Bacteria were pelleted by centrifugation at 12,000 × g for 30 min at room temperature and were washed twice with sterile PBS. Washed pellets were resuspended in sterile PBS to an OD of 1.0 at 650 nm (approximately 5 × 10 9 cfu/mL). Immediately before the phagocytic assay was conducted, P. multocida (5 × 10 8 per millimeter) was opsonized by mixing for 30 min at 41 C with 10% heatinactivated naive chicken serum. After opsonization, bacteria were diluted in RPMI to a concentration of 10 8 cfu/mL and incubated with chicken phagocytes (10 6 cells/mL) for 1 h. For each strain, bacterial concentration was confirmed by standard dilution and plate counts.
Preparation of Chicken Phagocytes
A chicken mononuclear cell line, MQ-NCSU (Qureshi et al., 1990) was employed in these studies. These cells are phagocytic, secrete tumoricidal factor, and exhibit morphological and cell surface antigen characteristics unique to mononuclear phagocytic lineage cells. The MQ-NCSU cells were grown in Leibovitz-McCoy's complete medium (Qureshi et al., 1990 ) at 41 C with 5% CO 2 in a humidified chamber. The MQ-NCSU macrophages were harvested from flasks by gentle scraping, centrifuged, and the viable cell concentration was determined by trypan blue dye exclusion and adjusted to 5 × 10 5 cells/mL. To obtain adherent MQ-NCSU cell monolayers, 2 mL of this cell suspension was plated into each well of 24-well tissue culture plates at a density of 5 × 10 5 cells/mL in RPMI 1640 medium supplemented with 10% chicken serum. The plates were then incubated at 41 C in a humidified incubator with 5% CO 2 for 24 h.
Chicken monocyte-derived macrophages and heterophils were isolated from the blood of 5-to 7-wk-old chickens using published procedures (Andreasen et al., 1991; Latimer et al., 1989; Madyastha et al., 1982) . For each experiment, 5 mL of blood was drawn from the wing vein of at least five Cornish cockerels 7 into disodium EDTA Vacutainer tubes. 8 The blood was mixed with 1% methylcellulose in RPMI 1640 at a 1.5:1 ratio and centrifuged for 10 min at 25 × g. The extended buffy coat (20 mL) was carefully layered over a preconstructed discontinuous Histopaque 1.077/1.119 (10 mL over 10 mL) density gradient. The gradient was centrifuged for 30 min at 250 × g. The medium buffy coat at the medium/ 1.077 interface (monocytes), and the 1.119 layer (heterophils) were resuspended in RPMI 1640. After three washes in RPMI 1640, the cell pellet was resuspended in the same medium. Both monocyte and heterophil purity and viability were routinely verified by visually identifying cells in cytocentrifuge preparations. Purity and cell viability were consistently > 95%.
Monocytes were seeded at a concentration of 5 × 10 5 cells/cm 2 in 75 cm 2 culture flask. After a 2 h incubation period, nonadherent cells were removed by washing then incubation at 41 C was continued with the addition of fresh medium. Pure macrophage (also known as monocyte-derived macrophages) cultures developed within 2 d of incubation with a yield of 1 × 10 5 adherent cells/cm 2 . After gentle scraping, these monocyte-macrophages were prepared identically to the MQ-NCSU macrophages. Heterophils were seeded at a concentration of 1 × 10 6 cells/mL in sterile tubes and used immediately.
Animal use in this study was conducted in accordance with the guidelines of the Eli Lilly Animal Care and Use Committee.
Intracellular Volume Determinations
The intracellular volume of the cells was determined by using [ 3 H]-water and [ 14 C]-carboxyinulin as described by Rottenberg (1979) . To 1 mL of the cell suspension (1 × 10 6 cells/mL), 50 mL of [ 3 H]-water (0.5 mCi) and 100 mL of a solution of [ 14 C]-carboxyinulin (0.5 mCi) in Sorensen Buffer were added. The mixture was left at 41 C for 2 min, then cells were separated from extracellular fluid by velocity gradient (silicone oil) centrifugation (12,000 × g; 3 min), and counted in a liquid scintillation counter. The total water content of the cell pellet was corrected for trapped extracellular water, i.e., carboxyinulin space, to obtain the intracellular water space. This space (microliters) was divided by the protein content of 1 × 10 6 cells determined by the method of Lowry et al. (1951) , to obtain the intracellular volume of each type of phagocyte.
Procedure for Determining the Uptake of Radiolabeled Antibiotic
The uptake method utilized in this study was the same as that described by Carlier et al. (1987) . All experiments were conducted in 24-well plates (2 mL per well), at an initial density of 5 × 10 5 cells/mL (MQ-NCSU macrophages and monocyte-macrophages). After overnight incubation, the culture medium was removed by aspiration, the adherent cells were washed with prewarmed PBS (pH 7.2) and incubated in the presence of 10 mg/mL of [ 14 C]-tilmicosin unless otherwise stated. At each of several incubation periods, the cells were washed four times to remove extracellular antibiotic, by using ice-cold PBS, (a procedure requiring less than 1 min). For nonadhering cells (heterophils), a similar procedure was used, except that every step of medium removal and cell washing was made by bringing the cells in suspension by gentle shaking and separating them from the suspension medium by centrifugation at 250 × g for 10 min at 4 C. The scraped or resuspended cells (in 1 mL of sterile water) were lysed by vortex agitation for 15 s, and the amount of radioactivity was determined in a liquid scintillation counter. This lysis procedure gave results similar to the use of 0.5% Triton X-100 or ultrasonication (50 Watts, 10 s). The concentration of antibiotic was then determined from a standard curve prepared with various dilutions of the labeled drug. The amount of cellular protein in a sample of each cell lysate was also determined to ensure cell number continuity between samples. The amount of antibiotic associated with 1 mg of cellular protein was then determined and the cellular:extracellular concentration ratio (Cc:Ce) was calculated based on the cell volume measurements.
Characterization of Antibiotic Uptake
The effect of cell viability (10%, formaldehyde pretreatment, 30 min), environmental temperature (4 or 41 C), and pH (range pH 5.5 to 8.0; 4 h of incubation) on tilmicosin uptake by chicken phagocytes was determined. The metabolic inhibitors used in the present study were sodium cyanide (1 mM), an inhibitor of mitochondrial oxidative respiration, and potassium fluoride (1 mM), which inhibits glycolysis. Cells were exposed to these inhibitors for 30 min prior to washes and addition of tilmicosin.
The influence of phagocytosis and other cell membrane stimuli on tilmicosin uptake was also evaluated. Phagocytes were incubated for 1 h with ingestible particles (P. multocida at a ratio of 100 bacteria to 1 macrophage), or incubated 24 h with lipopolysaccharide (LPS; 5 mg/mL) or exposed to pentoxifylline (10 -4 M) for 30 min. After these incubations, cells were washed and incubated in the presence of tilmicosin for 4 h at 41 C.
The importance of lysosomal trapping on the uptake of tilmicosin was also evaluated by adding for 30 min compounds which neutralize lysosomal pH, i.e., ammonium chloride (10 mM), chloroquine (10 mM), and bafilomycin (1 mM). After a 30-min exposure, the cells were washed and incubated 4 h in the presence of tilmicosin at 41 C.
Measurement of Efflux (Release) of Tilmicosin
Phagocytes were incubated for 4 h in RPMI medium containing 10 mg/mL of [ 14 C]-tilmicosin, then the cells were rapidly washed with ice-cold PBS and reincubated in antibiotic-free medium. At each sample time, the cells were treated as described above. The requirements for metabolic energy and the influence of phagocytosis during the efflux process were determined in the same fashion as described in the section on characterization of tilmicosin uptake.
Cell Fractionation Experiments
Chicken cells were incubated with 10 mg/mL of radiolabeled tilmicosin at 41 C for 4 h, washed in cold PBS, and further washed with the homogenization medium (0.25 M sucrose, 3 mM imidazole pH 7.4, 1 mM EDTA for macrophages, and 0.34 M sucrose, 0.15 M NaCl for 9 Beckman Instruments, Inc., Fullerton, CA 92634-3100. 10 Falcon, Lincoln Park, NJ 07035. heterophils; Renard et al., 1987) . Cells were collected and homogenized using a Dounce tissue grinder with eight strokes of the tightly fitting pestle. Results of preliminary studies showed that these conditions did not cause marked destruction of the cytoplasmic granules such as the lysosomes. The homogenate was subjected to three successive centrifugations at low speed (200, 250, and 300 × g, 10 min) in order to remove the nuclei, unbroken cells, and large cellular debris.
The cytoplasmic extract was further fractionated into a granule fraction and a soluble fraction (supernatant) by centrifugation at 100,000 × g for 30 min (rotor 70 TI 9 ). After centrifugation, the amount of radioactivity was measured in the unfractionated, nucleus, granule and soluble fractions. In parallel, the activity of marker enzymes of the main subcellular components was determined as follows: for lysosomes, b-glucuronidase (Talalay et al., 1946) , and acid phosphatase (Sigma Diagnostic Kit No. 104-AL), 2 for cytosol, lactate dehydrogenase (Korzeniewski and Callewaert, 1983) . Protein was assayed by the method described by Lowry et al. (1951) .
Biochemical Analysis
The amount of lysosomal enzyme in a sample of each cell lysate incubated in the presence of 10 mg/mL of tilmicosin for 4 h was also determined and compared to a lysate of cells incubated without tilmicosin. The cellular concentration of acid phosphatase (Sigma Diagnostic Kit No. 104) 2 and the release of lysozyme (Litwack, 1955) , bglucuronidase (Talalay et al., 1946) , NO 2 - (Green et al., 1982) , and avidin (Green, 1965) were assessed.
In Vitro Demonstration of Transport and Delivery of Tilmicosin by Chicken Heterophils
In order to determine the potential for tilmicosin contained within heterophils to be passed to other cell types, 1 ×10 6 cells/mL monocyte-macrophages, in 24-well plates, were incubated 4 h with tilmicosin-loaded and washed heterophils (10 mg/mL; 1 m 10 6 cells/mL; 2 h of incubation). The heterophils were seeded in a cell culture insert 10 (0.45 mm pore size) and fitted into the 24-well plates. The intracellular concentration of tilmicosin in macrophages was determined as described above, for comparison, the intracellular accumulation of tilmicosin in macrophages incubated in the absence of heterophils was determined. In this case, macrophages were incubated with tilmicosin at the concentration that was found in heterophils after 2 h of incubation at 41 C.
Additionally, the potential for tilmicosin contained within heterophils to be transported and delivered was determined using the chemotaxis under agarose technique described by Frank et al. (1992) . Heterophils (1 × 10 6 cells/mL) were incubated at 41 C with or without tilmicosin (0.1 to 2.0 mg/mL) for 2 h and then were washed to remove extracellular antibiotic. After centrifugation, heterophils were concentrated in 25 mL of RPMI medium, and 8 mL of this suspension (3.2 × 10 5 heterophils) were placed in wells of a double-layer agar plate (chemotaxisand Trypticase soy-agar). After 3 h of incubation in the presence of formyl-methionine-leucine-phenylalanine (fMLP, 10 -7 M, a chemoattractant) or PBS (a control medium), heterophil migration toward the chemoattractant and medium wells was measured under a microscope after fixation and Giemsa staining. Some agar plates were inoculated with 10 mL (10 6 cfu/mL) of a suspension of an avian S. aureus after this 3-h period of migration and incubated overnight in a 41 C, 5% CO 2 atmosphere. The zones of inhibition of bacterial growth in the directions of the chemoattractant and medium wells were measured under a microscope.
Statistical Analysis
Tests for significant differences between two groups were done by Student's t test.
RESULTS
Intracellular Volume Determination
The NCSU macrophages, monocyte-macrophages, and heterophils were found to have cell volumes of 6.57, 4.32, and 3.67 mL/mg cellular protein, respectively. This volume could also be expressed as 0.78, 0.81 and 0.89 mL/ 10 6 cells, for each respective cell type. Figure 1 shows that tilmicosin was rapidly accumulated by chicken phagocytes during the first hour of exposure, reaching a cellular accumulation ratio (Cc:Ce) of approximately 20, 34, and 107, respectively, in MQ-NCSU macrophages, monocyte-macrophages, and heterophils. Thereafter, a slower uptake continued for up to 4 h, until a plateau phase was achieved, with a peak Cc:Ce ratio of 32, 66, and, 138, respectively, in MQ-NCSU macrophages, monocyte-macrophages, and heterophils. Observations with heterophils were discontinued after this time due to a loss of viability (not attributed to the presence of the high intracellular concentration of tilmicosin because this was also observed in cells unexposed to tilmicosin; 15 ± 3% viability after 24 h). No additional uptake was observed over the next 44 h of incubation by either type of macrophage.
Cellular Uptake of Tilmicosin
Preliminary in vitro uptake studies with tilmicosin had used an extracellular concentration of 10 mg/mL, so it was of interest to determine whether lower, more physiologically relevant concentrations of tilmicosin might be accumulated in a similar ratio. To address this issue, chicken phagocytes were incubated in the presence of tilmicosin concentrations ranging from 0.1 to 10 mg/mL (Table 1) . The results indicated a direct linear correlation between the extracellular concentration of tilmicosin and the degree of intracellular accumulation for each type of phagocyte (r 2 > 0.98). Heterophils had a greater accumulation of tilmicosin than did either of the macrophage populations (Cc:Ce after 4 h of incubation are respectively, 137.8 ± 4.6 in heterophils vs 32.7 ± 2.6 in MQ-NCSU macrophages vs 66.7 ± 2.0 in monocyte-macrophages).
An exploration of the metabolic basis for the rapid uptake of tilmicosin by chicken phagocytes was undertaken. The effects of temperature, cell viability (i.e., active metabolism), and specific metabolic inhibitors on uptake were determined (Table 2 ). Uptake of tilmicosin by chicken phagocytes was markedly depressed when the cells were incubated at 4 C. Tilmicosin was not appreciably concentrated in non-viable, but intact cells (exposed for 30 min to 10% phosphate-buffered formaldehyde and then washed). In contrast, uptake was not impaired by the presence of 20% of chicken serum in the medium. Specific inhibitors of cellular metabolism were examined for their influence on tilmicosin uptake. Neither sodium cyanide (1 mM), an inhibitor of mitochondrial oxidative respiration, nor potassium fluoride (1 mM), a glycolysis inhibitor, decreased tilmicosin accumulation by any of the three chicken phagocyte types.
It is known that a basic pH is optimal for macrolide uptake Gladue and Snider, 1990; Hand TABLE 3 . Effect of phagocytosis and cell membrane stimulation on uptake of tilmicosin by chicken phagocytes 1 Cells were incubated in presence of tilmicosin for 4 h (MQ-NCSU macrophages and monocyte-macrophages) or 1 h (heterophils). Values are mean ± standard errors of the mean from three experiments (n = 3).
2 Cells were incubated 1 h with preopsonized P. multocida (100 bacteria to 1 cell), washed, and reincubated for 4 h in presence of tilmicosin.
3 Cells were incubated 24 h (MQ-NCSU macrophages and monocytemacrophages) or 4 h (heterophils) with 5 mg/mL of LPS, washed, and tilmicosin added.
4 Cells were incubated with pentoxifylline (10 -4 M) for 30 min; tilmicosin was then added for 4 h. *Significantly different from control (P < 0.05). . Persistence of tilmicosin in MQ-NCSU macrophages (◊), monocyte-macrophages (o), and heterophils (π) following removal of extracellular drug. Phagocytes were exposed to tilmicosin for 4 h, washed, and then incubated in antibiotic-free medium for the designated times. Values are mean ± standard errors of the mean from three experiments (n = 3). and Hand, 1993) . Thus, the influence of pH on tilmicosin uptake by chicken phagocytes was evaluated (Figure 2 ). When the pH of the extracellular medium was reduced from 7.0 to 5.5, the uptake of tilmicosin in all three chicken phagocyte types was reduced by 76 (heterophils) to 81% (MQ-NCSU macrophages and monocyte-macrophages). An increase in the pH from 7.0 to 8.0 increased the uptake by approximately 49 (monocyte-macrophages and heterophils) to 57% (MQ-NCSU macrophages).
The influence of phagocytosis and other cell membrane stimulation on the uptake of radiolabeled tilmicosin by chicken phagocytes is shown in Table 3 . Phagocytosis of opsonized P. multocida (100:1 bacteria to phagocyte ratio) and cell stimulation (by either LPS or pentoxifylline) led to a significant increase (20 to 60%) in the Cc:Ce ratio of tilmicosin in all three types of chicken phagocytes as compared to the control.
It is well known that weak bases tend to become concentrated in acidic cellular compartments (deDuve et al., 1974; MacIntyre and Cutler, 1988) . Lysosomes are the most acidic compartment in cells, with a pH of about 5, and would therefore be expected to concentrate tilmicosin, as has been shown for other macrolides Wildfeuer et al., 1993; Mtairag et al., 1995) . Moreover, lysosomes possess an ATP-driven H + pump that maintains the acidic pH. In order to characterize the lysosomal accumulation of tilmicosin various inhibitors were examined for their effect on uptake. Chloroquine or ammonium chloride are able to raise lysosomal pH of eukaryotic cells (Ohkuma and Poole, 1978; Poole and Ohkuma, 1981; Krogstad and Schlesinger, 1987) . Bafilomycins are potent specific inhibitors of the enzymatic activity of different ATPases (Bowman et al., 1988; Furuchi et al., 1993) . Table 4 illustrates that the tilmicosin uptake, expressed as Cc:Ce ratio, for all three types of chicken phagocytes was significantly lower (50 to 80%) when the cells were treated with lysosomotropic agents or an ATPase inhibitor, for 30 min prior to incubation with tilmicosin.
Kinetics of Efflux
The kinetics and characteristics of tilmicosin release, or efflux, from chicken phagocytes were evaluated. Efflux of this antibiotic from phagocytes, after removal of extracellular drug was rapid and substantial ( Figure 3 ). Fifty percent of the intracellular tilmicosin was released within the first 30 min in all three chicken cell types; followed by a plateau period during which considerably less tilmicosin was released so that 30% of the cell-associated antibiotic remained after 4 h of incubation. Because previous experiments (described above) have indicated that bacteria can enhance the uptake of tilmicosin, the subsequent effect of cell membrane stimulation on tilmicosin efflux to the extracellular environment was examined (Table 5 ). It was observed that opsonized P. multocida significantly enhanced the release of tilmicosin from all three types of chicken phagocytes. However, the release was drastically reduced when reincubation was performed at 4 C.
Cell Fractionation Experiments
The distribution of [ 14 C]-tilmicosin and marker enzymes between the nuclear fraction, the granule fraction, and the cell supernatant after differential centrifugation of MQ-NCSU macrophages, monocyte-macrophages, and heterophils is shown in Tables 6a, 6b , and 6c, respectively. Enzymes (acid phosphatase or b-glucuronidase) of the lysosomes were predominantly collected in the granule fraction (82 to 87%), whereas lactate dehydrogenase was largely soluble and recovered in the supernatant (75 to 80%). About 61 to 88% of [ 14 C]-tilmicosin was collected in the granule fraction of the 3 chicken phagocyte types with the remainder mostly in the supernatant. Moreover, the accumulation of tilmicosin in the phagocytes did not modify the distribution of the marker enzymes between the various fractions (data not shown).
Biochemical Analysis
At a concentration of 10 mg/mL, tilmicosin significantly decreased the nitric oxide production relative to control cells in the three types of chicken phagocytes after 4 h of incubation (Table 7) . In contrast, tilmicosin significantly increased the amount of acid phosphatase, avidin, lysozyme, and b-glucuronidase within the phagocytes (Table 7) . In all cases, a more dramatic change was observed in MQ-NCSU macrophages than in the other two chicken phagocytes.
In Vitro Demonstration of Transport and Delivery of Tilmicosin by Chicken Heterophils
It was of interest to determine whether tilmicosinloaded phagocytes could serve as a potential reservoir so that when tilmicosin was effluxed to the extracellular environment, it could be taken up by another type of phagocyte (i.e., recycled). To address this question, after a 4 h co-incubation of monocyte-macrophages with either tilmicosin-loaded heterophils, or an equivalent amount of extracellular tilmicosin, we observed that the cellular: extracellular concentration ratio of tilmicosin in monocyte-macrophages incubated with heterophils was lower than it was when they were incubated with free tilmicosin (37.9 ± 1.6 vs 60.8 ± 0.9; P < 0.0002).
It was also of interest to determine whether tilmicosinloaded phagocytes could migrate to a site away from that of the original uptake, and efflux bio-active antibiotic. Initial chemotaxis experiments demonstrated that heterophils preincubated with tilmicosin at various concentrations (0.1 to 2 mg/mL) migrated 2.63 ± 0.22 mm toward the chemoattractant well but only 1.27 ± 0.18 mm toward the medium well (P < 0.001 for the difference between directed and nondirected migration). Phagocyte motility was not affected by tilmicosin at the concentrations used (0.1 to 2 mg/mL). The zone of bacterial growth inhibition by heterophils not exposed to tilmicosin was 0.42 ± 0.18 mm in the direction of the chemoattractant well and 0.20 ± 0.15 mm toward the medium well (Figure 4 ). The measurement of bacterial growth inhibition attributable to tilmicosin efflux by heterophils (after prior incubation with tilmicosin) was consistently greater in the direction of the chemoattractant well than in the direction of the medium well. For heterophils incubated with 2 mg/mL tilmicosin, the inhibition was 2.78 ± 0.17 mm in the direction of the chemoattractant and 1.48 ± 0.19 mm toward the medium well (P < 0.0009). Even for heterophils incubated in 0.1 mg/mL tilmicosin, inhibition of bacterial growth was significantly greater in the direction of chemoattractant (0.98 ± 0.17 mm) than in the direction of the medium well (0.52 ± 0.14 mm; P < 0.022); and greater than that by heterophils incubated without antibiotic (P < 0.017 toward chemoattractant; P < 0.050 toward medium well). The zone of inhibition of bacterial growth with tilmicosin alone at 6 mg/mL (approximating the estimated amount of drug associated with heterophils; see Discussion) showed a value of 1.80 ± 0.18 mm toward the medium well and 1.88 ± 0.16 mm toward the chemoattractant. These values are substantially less than those for the inhibition of bacterial growth in the direction of the chemoattractant well seen with heterophils incubated with 2 mg/mL of tilmicosin (2.78 ± 0.17 mm; P < 0.001).
DISCUSSION
The in vivo efficacy of macrolide antibiotics in food animals is a multifactorial event (direct inhibitory action, subinhibitory effects, and interactions with the host immune system; Kirst, 1997) . In this report, we provide information concerning the interaction of tilmicosin and chicken phagocytic cells that enables a better understanding of the mode of action resulting in clinical efficacy. In order to compare the Cc:Ce ratio of tilmicosin concentration in each type of chicken phagocytes, the cell volume was determined and also related to the number of cells. This procedure allowed a standardized comparison based on cell volume or cell number for the various types of phagocytes evaluated.
In the present study, tilmicosin was rapidly taken up and concentrated more efficiently by chicken heterophils (Cc:Ce = 120 at 4 h) than by chicken macrophages (Cc:Ce = 66 at 4 h). Of those macrolides evaluated to date, only azithromycin reached a similar concentration in human polymorphonuclear neutrophils (Cc:Ce = 120 at 3 h; Gladue et al., 1989) .
The rapid concentration of tilmicosin in chicken phagocytes could be due in part to its lipophilic properties, which favor passage through the lipid membranes of the chicken phagocytes. Thus, studies were performed to define the mechanism and characteristics of tilmicosin uptake in chicken phagocytes. The influence of cell viability, environmental temperature, pH, and metabolic inhibitors on tilmicosin accumulation by chicken phagocytes were determined. Many investigators have reported that uptake of antibiotics concentrated by phagocytic cells may be greatly influenced by these factors Gladue et al., 1989; Carlier et al., 1990; Gladue and Snider, 1990; Hand and Hand, 1993; Pascual et al., 1997) . The uptake of tilmicosin by chicken phagocytes was dependent on cell viability and physiological environmental temperature. The accumulation of tilmicosin in all three chicken phagocytes was inversely proportional to the pH. This behavior is consistent with the model of intracellular diffusion/ intralysosomal segregation of the weak organic bases proposed by deDuve et al. (1974) , and also reported by other authors Hand et al., 1987; Hand and Hand, 1993) . Hand et al. (1987) previously found that the uptake of roxithromycin by phagocytic cells required metabolic energy and was decreased by inhibitors of the predominant energy source in the specific cell. In contrast, the accumulation of tilmicosin by chicken phagocytes was not affected by fluoride, which inhibits glycolysis, or by cyanide, which inhibits the mitochondria oxidative respiration. These data are in agreement with the findings obtained by Gladue et al. (1989) and Hand and Hand (1993) , on the uptake of, respectively, azithromycin by human fibroblasts and dirithromycin by human neutrophils. Thus, the uptake of tilmicosin required viable cells, but was not dependent on metabolic activity.
The relative contribution of active vs passive transport in the uptake of antibiotics is difficult to determine. Passive transport processes are suggested by the direct relationship observed between extracellular concentration and intracellular concentration and by the inhibition of uptake by low temperature or fixation, either of which could decrease membrane fluidity and thus prevent diffusion. Although the extent of tilmicosin uptake was greater than usual for macrolides (erythromycin, roxithromycin; Carlier et al., 1987) by a passive transport process, one mechanism by which the diffusion of tilmicosin may have lead to enhanced intracellular accumulation is the tendency of basic compounds to be lysosomotropic and become trapped in lysosomes as a result of the acidic pH (deDuve et al., 1974; Renard et al., 1987) . The presence of two basic amine groups in the structure of tilmicosin (Bryskier et al., 1993) similar to azithromycin, may have allowed for greater ionization and lysosomal trapping than that which may occur with classical macrolides, such as erythromycin or roxithromycin, which contain only one basic amine group.
Thus as one would expect, acidic conditions did inhibit diffusion of tilmicosin into cells. The partial inhibition of tilmicosin uptake by bafilomycin might therefore be explained by inhibition of proton pump activity (Bowman et al., 1988; Furuchi et al., 1993) , which is required to maintain an acidic lysosomal pH (deDuve et al., 1974) .
A further evaluation of the nature of the subcellular distribution of tilmicosin was undertaken. Like other weak bases, tilmicosin (pKa = 7.4 and 8.5) would be expected to concentrate in the acidic lysosomes. The subcellular distribution experiments confirmed this hypothesis, as it was demonstrated that tilmicosin partly localized in lysosomes with the remaining intracellular antibiotic being apparently distributed in the cytosol. This intracellular fate of tilmicosin resembled that of several other macrolides tested in human and mouse phagocytic cells Wildfeuer et al., 1993; Mtairag et al., 1995) . Moreover, the observation that chloroquine, ammonium chloride, and bafilomycin, all agents which neutralize lysosomal pH or prevent protonation and trapping of weak bases (Poole and Ohkuma, 1981; Klempner and Styrt, 1983; Krogstad and Schlesinger, 1987) , significantly decreased the uptake of tilmicosin. These observations provide additional evidence on the importance of pH trapping as an explanation of lysosomal accumulation.
The influence of phagocytosis and other cell membrane stimulation on uptake of radiolabeled tilmicosin by chicken phagocytes was of interest because phagocytes will encounter bacteria in vivo (Hand et al., 1987; Gladue et al., 1989; Hand and Hand 1993) . Ingestion of microbial particles, in this case P. multocida, increased the ability of chicken phagocytes to accumulate tilmicosin. This enhancement of tilmicosin uptake by microbial particle ingestion is higher than what other investigators have demonstrated for roxithromycin or azithromycin in human neutrophils (Hand et al., 1987; Gladue et al., 1989) . Pentoxifylline, a methylxanthine derivative, has major effects (e.g., decrease of the respiratory burst response; inhibition of the ingestion of microbial particles) on mammalian cell membrane functions (Sullivan et al., 1988; Hand and Hand, 1995) . In the present study, pentoxifylline caused a significant increase in tilmicosin uptake. This result is similar to the results obtained by Hand and Hand (1995) with dirithromycin in human neutrophils. Thus, tilmicosin uptake by chicken phagocytes is enhanced by stimulation of the phagocyte's lipid membrane but the exact mechanism remains to be elucidated.
The efflux of tilmicosin from chicken phagocytic cells was quite rapid, with release of 50% of the total intracellular concentration occurring in the first 30 min after removal of the extracellular antibiotic. After 4 h, almost 30% of the initial intracellular tilmicosin was still cell-associated. These observations are in contrast to what others have observed with other highly concentrated antibiotics, which are either promptly released (erythromycin, roxithromycin; Carlier et al., 1987) or slowly released (dirithromycin, azithromycin; Gladue et al., 1989; Hand and Hand, 1993 ) from phagocytic cells upon removal of extracellular drug. The effect of exposure to microbial particles on the efflux process was evaluated, as phagocytosis was shown to increase the accumulation of tilmicosin by all the three chicken phagocytes. Exposure of tilmicosin-laden chicken phagocytes to opsonized P. multocida failed to increase its release.
The effects of macrolides on lysosomal enzyme exocytosis or degranulation is relatively unexplored (Labro, 1993; Abdelghaffar et al., 1994) . Some workers (Engquist et al., 1984; Anderson, 1989) have observed that human neutrophils incubated for 30 min in the presence of erythromycin (125 mg/mL), released significantly more protease than control cells. By contrast, Carevic and Djokic (1988) have reported that azithromycin decreased the release of intragranular enzymes by immune-complex-stimulated neutrophils. Abdelghaffa et al. (1994) observed that neutrophil exocytosis is clearly dependent both on the concentration and on the incubation time, and that low concentrations of macrolides (10 to 25 mg/mL) required a minimum of 2 to 3 h to be effective on exocytosis. The present study showed that tilmicosin at 10 mg/mL, after 4 h of incubation, increase specific cellular lysosomal production of all three chicken phagocyte types in a manner similar to what Abdelghaffar et al. (1994) observed with various macrolides at 100 mg/mL in human neutrophils.
The ability of heterophils to migrate preferentially to sites of infection makes them attractive as a delivery mechanism for antibiotics (Gladue et al., 1989; Mandell, 1994) . Theoretically, with the proper cellular pharmacokinetics, an antibiotic could be taken up by heterophils, which would then transport the drug and later release it. This uptake could provide a mechanism for achieving higher levels of antibiotic in tissues, i.e., directly at the nidus of infection where it is most needed. Using the method described by Frank et al. (1992) , it was shown that this type of transport and delivery by chicken heterophils is possible. After incubation with tilmicosin, heterophils migrated under agarose, and growth inhibition of bacteria inoculated on the agar surface showed the location and relative concentration of bioactive drug released. Because the heterophils were washed to remove extracellular tilmicosin, any antibiotic in the system must have been cell-associated. In addition, growth inhibition was significantly greater in the direction of heterophil chemotaxis to fMLP. This result demonstrated that the release of bioactive tilmicosin by heterophils occurred after migration, as antibiotic released while the heterophils were still in the well would produce an equal inhibition in both directions. In fact, the inhibition followed a dose-response relationship, which correlated with the observation that intracellular tilmicosin accumulation varied directly with extracellular concentration. An alternative explanation for the results seen with tilmicosin is that the inhibition of bacterial growth was not directly due to antibiotic but rather to an increased release of heterophil antimicrobial compounds. This explanation is unlikely because heterophils incubated without antibiotic (and already stimulated by fMLP) produced minimal inhibition of bacteria growth. In order to explore this more fully, we looked at the zone of inhibition of bacterial growth resulting from filling the sample well with tilmicosin alone (i.e., without heterophils). The mass of antibiotic remaining in 8 mL of a heterophil cell pellet after a 2 h incubation with antibiotic, followed by washing, can be roughly estimated by the formula (Frank et al., 1992) Cc:Ce × Cc × 0.0009 mL × percentage retention × 32%, where Cc:Ce is the ratio of cellular to extracellular concentration after 2 h, Ce is the extracellular concentration in micrograms per milliliter; 0.0009 mL is the volume of 1 × 10 6 chicken heterophils; percentage retention is the fraction remaining intracellular 20 min after removal of extracellular antibiotic; and 32% is the fraction of the cell pellet placed in the well (8 mL of the 25-mL pellet). For heterophils incubated in 2 mg of tilmicosin/mL, Cc:Ce is 120 and the percentage retention is 68.9%, so that the estimated mass of total intracellular tilmicosin placed in each heterophils well was 0.048 mg. We used 0.048 mg (8 mL of 6 mg/mL tilmicosin) in the experiments determining zones of inhibition by tilmicosin without heterophils. The consequent zone of inhibition was comparable to that seen with heterophils incubated with tilmicosin in the direction of the medium but was considerably smaller in the direction of the chemoattractant. These calculations suggest that release of tilmicosin occurred after migration toward the chemoattractant.
Furthermore, the release of tilmicosin from heterophils may allow activity against invading extracellular pathogens and potential accumulation by other phagocytic cells as they pass through tissues. This accumulation was demonstrated in vitro, where monocyte-derived macrophages incubated in the presence of tilmicosinloaded heterophils accumulated tilmicosin, but not to the same extent as achieved by incubating monocytederived macrophages with tilmicosin alone. This result implied that macrophages could "pick up" extracellular tilmicosin, originally contained in "loaded" heterophils, as it was released locally. Once concentrated in these cells, there might be continued transport of tilmicosin to the site of infection, again producing locally high concentrations of active drug.
The uptake and the later release of tilmicosin by phagocytes may provide a unique means of delivering tilmicosin to sites of infection and may explain in part why tilmicosin is effective in vivo against avian pathogens such as M. gallisepticum and M. synoviae (Shryock et al., 1994; Jordan and Horrocks, 1996) . Tilmicosin not only concentrated in chicken phagocytes but was also maintained, for at least 4 h, even in the absence of extracellular antibiotic, which suggested that, in vivo, phagocytic cells could retain tilmicosin even though levels in serum may be negligible. Furthermore, the rapid release of tilmicosin in the presence of bacteria, demonstrated in vitro, may produce locally high concentrations of active drug. Thus, intracellular concentrations of tilmicosin in peripheral blood and tissue may be more relevant to in vivo anti-infective activity than the concentrations in serum or plasma or even in lung homogenates, which have been classically used for predicting antibacterial efficacy.
In summary, these in vitro studies of the interactions between tilmicosin and chicken phagocytes have yielded a number of interesting and important findings. There was a marked accumulation of tilmicosin by chicken heterophils, but also in monocyte-macrophages. Furthermore, we showed that tilmicosin was partly localized in lysosomes. The cellular retention of the huge intracellular pool of tilmicosin in phagocytes has exciting therapeutic implications.
By virtue of prolonged retention in phagocytic cells, which then migrate to sites of infection, the tilmicosinphagocyte association constitutes a valid antibiotic delivery system. Coupled with the enhanced release of tilmicosin from phagocytes in the presence of bacteria, it is possible that tilmicosin could be delivered as a "sustained-release", antimicrobial agent at infection sites. Further in vivo and ex vivo work is necessary to explore the therapeutic implications of these findings.
